RecallDepth
Class I Terminated

Hydromorphone, Hydrochloride, Injection, USP CII, 10 mg/mL, Rx Only, 1 mL Single-dose Vial, High Potency Formulation. Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618. NDC: 0703-0110-01

Company
Pfizer Inc.
Recall Initiated
February 7, 2018
Posted
March 21, 2018
Recall Number
D-0596-2018
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
53600 vials
Firm Location
New York, NY, United States

Reason for Recall

Non-Sterility: Confirmed customer complaints of glass product container vials that may be empty or cracked.

Distribution

Nationwide in the USA

Lot / Code Info

Lots # 691853F, EXP. 9/1/2018; 700753F, EXP. 10/1/2018.

More recalls by Pfizer Inc.

View all recalls by this company →

Other recent Class I Drug recalls